Globus Medical (GMED) reported Q2 adjusted earnings late Thursday of $1.34 per diluted share, up from $0.86 a year earlier.
Analysts polled by FactSet expected $1.10.
Revenue for the three months ended June 30 was $789.6 million, up from $745.3 million a year earlier.
Analysts expected $782.9 million.